[Participation of dopamine on the muscarinergic inhibitory effect of substance P on gastric myoelectric activity and motility].
Our previous study showed that microinjection of substance P (SP) into caudate nucleus inhibits gastric myoelectric fast wave and gastric motility, an effect mediated by muscarinic receptor. The present investigation showed that this effects of SP could be blocked by coinjected SP antiserum or SP antagonist [Arg6, D-Trip7,9, MePhe8]-SP6-11 or D2 dopamine antagonist haloperidol. In addition, microinjection of dopamine (DA) into caudate nucleus could also inhibit gastric fast wave and motility, an effect again being blockable by coinjected DA antagonist haloperidol or atropine. Thus, it appears that the muscarinergic inhibitory effect of SP on gastric fast wave and motility is mediated by D2 dopamine receptor.
Jing
H
H
Department of Physiology, Dalian Medical University.
Lin
K W
KW
Mei
M H
MH
D000818:Animals; D002421:Caudate Nucleus / Q000502:physiology*; D004298:Dopamine / Q000502:physiology*; D018492:Dopamine Antagonists / Q000494:pharmacology; D005769:Gastrointestinal Motility / Q000187:drug effects*; D006220:Haloperidol / Q000494:pharmacology; D008297:Male; D051379:Mice; D017448:Receptors, Dopamine D2 / Q000187:drug effects; D011976:Receptors, Muscarinic / Q000187:drug effects* / Q000502:physiology; D013373:Substance P / Q000037:antagonists & inhibitors*
D018492:Dopamine Antagonists; D017448:Receptors, Dopamine D2; D011976:Receptors, Muscarinic; D013373:Substance P; D006220:Haloperidol; D004298:Dopamine